- Salt and polymorph screening
- Particle engineering and solid form selection
- Pre-formulation and formulation development for oral (IR/MR), parenteral (sterile/lyophilised), inhalation, topical, and transdermal delivery systems
- Excipients selection and compatibility evaluation
Develops stable, bioavailable, and patient-centric dosage forms through a science-driven understanding of physicochemical properties and formulation behaviour.